Cargando…

Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis

Over the past two decades a number of studies have demonstrated activity of the retroviral enzyme reverse transcriptase in the serum of patients with sporadic amyotrophic lateral sclerosis (ALS). Known human exogenous retroviruses such as HIV-1 have been eliminated as possible sources of this activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Garson, Jeremy A., Usher, Louise, Al-Chalabi, Ammar, Huggett, Jim, Day, Edmund F., McCormick, Adele L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421708/
https://www.ncbi.nlm.nih.gov/pubmed/30885274
http://dx.doi.org/10.1186/s40478-019-0698-2
_version_ 1783404279505092608
author Garson, Jeremy A.
Usher, Louise
Al-Chalabi, Ammar
Huggett, Jim
Day, Edmund F.
McCormick, Adele L.
author_facet Garson, Jeremy A.
Usher, Louise
Al-Chalabi, Ammar
Huggett, Jim
Day, Edmund F.
McCormick, Adele L.
author_sort Garson, Jeremy A.
collection PubMed
description Over the past two decades a number of studies have demonstrated activity of the retroviral enzyme reverse transcriptase in the serum of patients with sporadic amyotrophic lateral sclerosis (ALS). Known human exogenous retroviruses such as HIV-1 have been eliminated as possible sources of this activity and investigators have therefore considered the possibility that human endogenous retroviruses (HERVs) might be involved. HERV-K (HML-2) is the most recent retroviral candidate to be proposed following the observation of elevated HERV-K expression in cortical and spinal neurons of ALS patients and the demonstration of HERV-K envelope protein neurotoxicity in vitro and in transgenic mice. This retroviral hypothesis is an attractive one, not least because it raises the possibility that ALS might become treatable using antiretroviral drugs. In the present study we have attempted independent confirmation of the observation that HERV-K RNA levels are elevated in ALS brain. Total RNA was extracted from the postmortem premotor cortex of 34 patients with ALS and 23 controls. Quantitative real-time reverse transcription PCR (RT-qPCR) was performed according to the MIQE guidelines using HERV-K gag, pol and env primer sets. Data was analysed by the 2(-∆∆Ct) method with normalisation against two reference genes, GAPDH and XPNPEP1. Geometric mean HERV-K RNA expression levels in the premotor cortex of ALS patients were not found to be different from the expression levels in non-ALS controls. Our findings do not confirm the recently reported association between elevated cortical HERV-K RNA levels and ALS, and thus raise doubts about the role of this endogenous retrovirus in ALS pathogenesis. The results of this study may have implications for ongoing clinical trials aiming to suppress HERV-K activity with antiretroviral drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0698-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6421708
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64217082019-03-28 Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis Garson, Jeremy A. Usher, Louise Al-Chalabi, Ammar Huggett, Jim Day, Edmund F. McCormick, Adele L. Acta Neuropathol Commun Research Over the past two decades a number of studies have demonstrated activity of the retroviral enzyme reverse transcriptase in the serum of patients with sporadic amyotrophic lateral sclerosis (ALS). Known human exogenous retroviruses such as HIV-1 have been eliminated as possible sources of this activity and investigators have therefore considered the possibility that human endogenous retroviruses (HERVs) might be involved. HERV-K (HML-2) is the most recent retroviral candidate to be proposed following the observation of elevated HERV-K expression in cortical and spinal neurons of ALS patients and the demonstration of HERV-K envelope protein neurotoxicity in vitro and in transgenic mice. This retroviral hypothesis is an attractive one, not least because it raises the possibility that ALS might become treatable using antiretroviral drugs. In the present study we have attempted independent confirmation of the observation that HERV-K RNA levels are elevated in ALS brain. Total RNA was extracted from the postmortem premotor cortex of 34 patients with ALS and 23 controls. Quantitative real-time reverse transcription PCR (RT-qPCR) was performed according to the MIQE guidelines using HERV-K gag, pol and env primer sets. Data was analysed by the 2(-∆∆Ct) method with normalisation against two reference genes, GAPDH and XPNPEP1. Geometric mean HERV-K RNA expression levels in the premotor cortex of ALS patients were not found to be different from the expression levels in non-ALS controls. Our findings do not confirm the recently reported association between elevated cortical HERV-K RNA levels and ALS, and thus raise doubts about the role of this endogenous retrovirus in ALS pathogenesis. The results of this study may have implications for ongoing clinical trials aiming to suppress HERV-K activity with antiretroviral drugs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0698-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-18 /pmc/articles/PMC6421708/ /pubmed/30885274 http://dx.doi.org/10.1186/s40478-019-0698-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Garson, Jeremy A.
Usher, Louise
Al-Chalabi, Ammar
Huggett, Jim
Day, Edmund F.
McCormick, Adele L.
Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis
title Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis
title_full Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis
title_fullStr Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis
title_full_unstemmed Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis
title_short Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis
title_sort quantitative analysis of human endogenous retrovirus-k transcripts in postmortem premotor cortex fails to confirm elevated expression of herv-k rna in amyotrophic lateral sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421708/
https://www.ncbi.nlm.nih.gov/pubmed/30885274
http://dx.doi.org/10.1186/s40478-019-0698-2
work_keys_str_mv AT garsonjeremya quantitativeanalysisofhumanendogenousretrovirusktranscriptsinpostmortempremotorcortexfailstoconfirmelevatedexpressionofhervkrnainamyotrophiclateralsclerosis
AT usherlouise quantitativeanalysisofhumanendogenousretrovirusktranscriptsinpostmortempremotorcortexfailstoconfirmelevatedexpressionofhervkrnainamyotrophiclateralsclerosis
AT alchalabiammar quantitativeanalysisofhumanendogenousretrovirusktranscriptsinpostmortempremotorcortexfailstoconfirmelevatedexpressionofhervkrnainamyotrophiclateralsclerosis
AT huggettjim quantitativeanalysisofhumanendogenousretrovirusktranscriptsinpostmortempremotorcortexfailstoconfirmelevatedexpressionofhervkrnainamyotrophiclateralsclerosis
AT dayedmundf quantitativeanalysisofhumanendogenousretrovirusktranscriptsinpostmortempremotorcortexfailstoconfirmelevatedexpressionofhervkrnainamyotrophiclateralsclerosis
AT mccormickadelel quantitativeanalysisofhumanendogenousretrovirusktranscriptsinpostmortempremotorcortexfailstoconfirmelevatedexpressionofhervkrnainamyotrophiclateralsclerosis